Onderneming Argenica Therapeutics Limited
Aandelen
AGN
AU0000150328
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,56 AUD | +2,75% | -5,08% | +9,80% |
16/04 | ARGENICA THERAPEUTICS LIMITED : Euroz Hartleys herhaalt koopadvies | ZM |
28/03 | Argenica Therapeutics doneert eerste patiënt in Fase Twee Studie naar Beroerte; Aandelen stijgen met 14% | MT |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Emma Waldon
DFI | Director of Finance/CFO | - | - |
Meghan Thomas
CTO | Chief Tech/Sci/R&D Officer | - | 04-04-22 |
Bruno Meloni
CTO | Chief Tech/Sci/R&D Officer | - | - |
Celina Chewas
PRN | Corporate Officer/Principal | - | 22/11 |
Samantha South
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Terry C. Budge
BRD | Director/Board Member | 72 | - |
Geoff Pocock
BRD | Director/Board Member | - | - |
Dianne Angus
BRD | Director/Board Member | 63 | 01/12 |
McCall Liddy
BRD | Director/Board Member | - | - |
Samantha South
PRN | Corporate Officer/Principal | - | - |
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 99 150 822 | 64 605 696 ( 65,16 %) | 0 | 65,16 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,80% | 44,63 mln. | |
+4,09% | 43,84 mld. | |
+9,45% | 41,68 mld. | |
+45,72% | 41,25 mld. | |
-10,92% | 27,04 mld. | |
+9,32% | 25,53 mld. | |
-24,87% | 18,18 mld. | |
+1,28% | 12,29 mld. | |
+29,70% | 12,29 mld. | |
+7,78% | 11,15 mld. |